Immunic (IMUX) Minority Interest (2013 - 2014)

Immunic's (IMUX) quarterly Minority Interest came in at $103.3 million in Q1 2014, up 25.86% quarter-over-quarter from $82.1 million in Q4 2013.

Immunic (IMUX) Minority Interest (2013 - 2014) Analysis & Trends

Immunic has disclosed Minority Interest across 2 years of filings, most recently posting $103.3 million for Q1 2014.

Minority Interest for Q1 2014 came in at $103.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2014 was $103.3 million (changed N/A YoY), and the FY2013 annual result was $82.1 million, changed N/A from the prior year.
Minority Interest came in at $103.3 million for Q1 2014 at Immunic, up from $82.1 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $103.3 million in Q1 2014 to a low of $82.1 million in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn
9	Abivax	94.26 Bn	94.26 Bn	-
10	Immunic	384.84 Mn	198.21 Mn	-

Download Data

Date	Value
Mar 31, 2014	103.35 Mn
Dec 31, 2013	82.12 Mn